The Sputum GeneXpert test is a molecular diagnostic test that detects tuberculosis (TB) DNA and drug-resistant strains in sputum samples.

Unlike traditional TB tests, the GeneXpert test provides faster results and can detect drug-resistant strains of TB by analyzing genetic material.

No special preparation is required. Provide a sputum sample, ideally collected in the morning, and follow any specific instructions from your healthcare provider.

Results are usually available within 1 to 2 days after the sample is processed, providing a rapid diagnosis.

The test offers accurate and quick detection of TB and drug-resistant strains, which is crucial for effective treatment and control of TB infections.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Candidates include men with erectile dysfunction unresponsive to other treatments, Peyronie’s disease, or post-surgical erectile issues.